Trial intelligence / Profile preview

Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy Adults

NCT01089660Phase 2Completed

Sponsor
Sanofi
Start
Mar 2010
Primary completion
Sep 2010
Modality
Live Biotherapeutic Products, Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of influenza A (H1N1) 2009 monovalent vaccine in influenza A H1N1 infection (H1N1), sponsored by Sanofi. Started Mar 2010; status: completed.

02

Drugs

influenza A (H1N1) 2009 monovalent vaccine
03

Conditions

influenza A H1N1 infection (H1N1)

Beyond the preview

Go deeper on NCT01089660.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01089660.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call